Showing 45,721 - 45,740 results of 226,405 for search '(( a ((((teer decrease) OR (a decrease))) OR (linear decrease)) ) OR ( a large decrease ))', query time: 2.13s Refine Results
  1. 45721

    Cryotherapy: biochemical alterations involved in reduction of damage induced by exhaustive exercise by A.B.V. Furtado (5836688)

    Published 2018
    “…The SEP+CWI group showed a decrease in inflammatory damage biomarkers, and reactive species production, and presented increased cell viability compared to the SEP group. …”
  2. 45722

    Data_Sheet_4_Fasting Intervention for Children With Unilateral Renal Tumors to Reduce Toxicity.pdf by Christiaan A. J. Oudmaijer (12006320)

    Published 2022
    “…In Europe, the SIOP-RTSG approach is considered standard of care and has resulted in five-year survival rates of over 90%. Efforts to decrease toxicity are now being pursued. Short-term fasting (STF), a short but strong reduction in calorie-intake, is associated with improved fitness, enhanced coping with acute physical stress and a lower risk of age-associated diseases. …”
  3. 45723

    Inhibition of RhoA by Rhosin blocked phosphorylation of myosin light chain and platelet shape change. by Huzoor Akbar (340517)

    Published 2016
    “…<b>(C-D)</b> Aspirin (1 mM) treated washed human platelets containing apyrase (3 U/ml) were incubated with U46619 (0.01 μM) or thrombin (0.005 U/ml) and platelet shape change was recorded as a decrease in light transmittance using a Lumi-Aggregometer. …”
  4. 45724

    <i>Drosophila</i> Spidey/Kar Regulates Oenocyte Growth via PI3-Kinase Signaling by Einat Cinnamon (2922108)

    Published 2016
    “…Several enzymes of fatty acid, triglyceride and hydrocarbon metabolism are required in oenocytes primarily for lipid droplet induction rather than for cell growth. In contrast, a very long chain fatty-acyl-CoA reductase (FarO) and a putative lipid dehydrogenase/reductase (Spidey, also known as Kar) not only promote lipid droplet induction but also inhibit oenocyte growth. …”
  5. 45725

    Plasma activated water as resistance inducer against bacterial leaf spot of tomato by Set Madian Perez (6786653)

    Published 2019
    “…In this work, cold atmospheric pressure plasma (CAP) was applied to sterile distilled water, inducing the production of a hydrogen peroxide, nitrite and nitrate, and a pH reduction. …”
  6. 45726
  7. 45727

    <b>Changes to plant traits of two functional types across a soil water content gradient in a tropical dry forest impact tree growth rates</b> (Data sheet and R-code) by Ravi Chaturvedi (17312020)

    Published 2023
    “…Our study aimed to understand shifts in trait means and variabilities, species composition, and structure and productivity of a tropical dry forest assemblage, across a soil water content (SWC) gradient using 45 dry forest fragments. …”
  8. 45728
  9. 45729
  10. 45730
  11. 45731
  12. 45732
  13. 45733

    Measurement and 3D-Visualization of Cell-Cycle Length Using Double Labelling with Two Thymidine Analogues Applied in Early Heart Development by Bouke A. de Boer (127014)

    Published 2012
    “…Later in development, a local increase in cell size was found to be associated with a decrease in cell cycle length in the region where the chamber myocardium starts to develop. …”
  14. 45734
  15. 45735
  16. 45736
  17. 45737
  18. 45738

    Longitudinal phenotypic study of late-onset retinal degeneration due to a founder variant c.562C>A p.(Pro188Thr) in the <i>C1QTNF5</i> gene by Julie De Zaeytijd (3633118)

    Published 2021
    “…</p> <p><b>Results</b>: Best-corrected visual acuity (BCVA) and visual fields were maintained up to 50 to 55 years (n = 8), with a gradual decline, but conservation of functional central vision between 55 to 65 years (n = 15), followed by a steep decrease in overall visual function beyond 65 years (n = 9). …”
  19. 45739

    An idealized view of the opportunity provided by a comparative and integrated oncology drug development path. by Ira Gordon (369869)

    Published 2013
    “…Factoring in additional costs for comparative studies with this approach of US$150,000 for studies conducted in the preclinical setting, US$250,000 for studies conducted before or during Phases I–II human trials and US$1 million for studies conducted before Phases II–III studies, the total cost of development is estimated at US$2.07 billion. The result may be a decrease in average clinical trial costs per approved drug from US$290 million to US$173 million <a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000161#pmed.1000161-Adams1" target="_blank">[5]</a>.…”
  20. 45740

    BC CLC-Pred: a freely available web-application for quantitative and qualitative predictions of substance cytotoxicity in relation to human breast cancer cell lines by A.A. Lagunin (810465)

    Published 2023
    “…Based on leave-one-out and 5F CV procedures, 24 reasonable (Q)SAR models were selected for the creation of a freely available web-application (BC CLC-Pred: <a href="https://www.way2drug.com/bc/" target="_blank">https://www.way2drug.com/bc/</a>) to predict substance cytotoxicity in relation to human breast cancer cell lines. …”